New Study Shows That Biosimilar Retacrit™ Effective in Chemotherapy-Induced Anemia
Hospira, the globe’s major supplier of injectable medicines and infusion technologies, reported today that the outcomes from the ORHEO research
Read moreHospira, the globe’s major supplier of injectable medicines and infusion technologies, reported today that the outcomes from the ORHEO research
Read moreThe oncology drug by Hospira, a gemcitabine injection, has received approval from the US Food and Drug Administration (FDA), and
Read more